Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 2/20 | 0.42 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.36 |
| ▸ | NQO2 | P16083 | 1/20 | 0.36 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5680499 | 0.84 | HTR1A (0.43) | HTR1ACSNK2A1HTR2AIDO1HTR6 | |
| SCHEMBL8544872 | 0.84 | CSNK2A1 (0.38) | HTR1ACSNK2A1HTR2AGPR84 | |
| SCHEMBL8549571 | 0.83 | HTR1B (0.37) | HTR1ACSNK2A1HTR2A | |
| SCHEMBL8869470 | 0.81 | CSNK2A1 (0.38) | CSNK2A1HTR2AGPR84 | |
| Arvelexin SCHEMBL2725123 | 0.79 | HTR2A (0.62) | HTR1AHTR2AHTR6MTNR1AMTNR1B | |
| SCHEMBL7334679 | 0.79 | PRKAB2 (0.38) | HTR1ACSNK2A1HTR2AHTR6GPR84 | |
| SCHEMBL8549558 | 0.79 | HTR2A (0.45) | CSNK2A1HTR2AHTR6 | |
| SCHEMBL2541508 | 0.78 | HTR2A (0.65) | HTR1AHTR2AHTR6 | |
| SCHEMBL8546408 | 0.78 | HTR1A (0.52) | HTR1AHTR2AIDO1HTR6MTNR1A | |
| SCHEMBL8544722 | 0.77 | HTR2A (0.53) | HTR1AHTR2AIDO1HTR6MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0593513-B1 | TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES | SMITHKLINE BEECHAM PLC (GB) | 1998-10-28 | — | — | EP | disclosed |
| US-5571833-A | TREATMENT OF MIGRAINE, PORTAL HYPERTENSION | SMITHKLINE BEECHAM PLC (GB) | 1996-11-05 | — | — | US | disclosed |
| EP-0593513-A1 | TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES | SMITHKLINE BEECHAM PLC (GB) | 1994-04-27 | — | — | EP | disclosed |
| WO-1993000333-A1 | TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1993-01-07 | — | — | WO | disclosed |